CA-based 9amHealth secures $9.5million in series A round extension funding. Leaps by Bayer, Founders Fund, Define Ventures, 7Wire Ventures, and other current investors participated in the round, which was led by The Cigna Group Ventures.

Read also – CA-based Freenome Secures $254Million in Funding

The money will be used by the company to further scale its current solutions, accelerate its growth strategy, and add more doctors, medical consultants, and care professionals to its internal staff.

Established in 2021 by Frank Westermann and Anton Kittelberger, 9amHealth provides comprehensive cardiometabolic care, utilising a whole-body approach to prevent and cure high blood pressure, diabetes, obesity, and high cholesterol.

Read also – CA-based Point2 Technology Secures Additional $22.6Million in Series B Round Funding

They collaborate with companies to offer people with chronic illnesses efficient health benefits. Personalised care plans, prescription delivery, at-home lab testing, and unrestricted access to specialists are all provided to members.

About 9amHealth

Complete cardiometabolic care is provided by 9amHealth, a revolutionary whole-body strategy for the prevention and treatment of diabetes, obesity, high cholesterol, and hypertension. They collaborate with companies who want to lower overall healthcare expenses while offering their members meaningful health benefits.

Read also – Canada-based Armilla AI Secures $4.5Million in Seed Funding